HK1171013A1 - Inhibitors of akt activity akt - Google Patents

Inhibitors of akt activity akt

Info

Publication number
HK1171013A1
HK1171013A1 HK12111698.8A HK12111698A HK1171013A1 HK 1171013 A1 HK1171013 A1 HK 1171013A1 HK 12111698 A HK12111698 A HK 12111698A HK 1171013 A1 HK1171013 A1 HK 1171013A1
Authority
HK
Hong Kong
Prior art keywords
akt
inhibitors
activity
akt activity
activity akt
Prior art date
Application number
HK12111698.8A
Other languages
English (en)
Chinese (zh)
Inventor
Lixin Zhang
Graham Peter Trevitt
Hughes Miel
Frank Burkamp
Timothy Harrison
Andrew John Wilkinson
Charles-Henry Fabritius
Original Assignee
Almac Discovery Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Almac Discovery Ltd filed Critical Almac Discovery Ltd
Publication of HK1171013A1 publication Critical patent/HK1171013A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/14Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Quinoline Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK12111698.8A 2009-12-23 2012-11-16 Inhibitors of akt activity akt HK1171013A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0922589.7A GB0922589D0 (en) 2009-12-23 2009-12-23 Pharmaceutical compounds
PCT/GB2010/002329 WO2011077098A1 (fr) 2009-12-23 2010-12-23 Inhibiteurs de l'activité de l'akt

Publications (1)

Publication Number Publication Date
HK1171013A1 true HK1171013A1 (en) 2013-03-15

Family

ID=41716932

Family Applications (1)

Application Number Title Priority Date Filing Date
HK12111698.8A HK1171013A1 (en) 2009-12-23 2012-11-16 Inhibitors of akt activity akt

Country Status (22)

Country Link
US (1) US9221838B2 (fr)
EP (1) EP2516435B8 (fr)
JP (1) JP5923043B2 (fr)
KR (1) KR20140015157A (fr)
CN (1) CN102791708B (fr)
AU (1) AU2010334591C1 (fr)
BR (1) BR112012015677A2 (fr)
CA (1) CA2783340C (fr)
CY (1) CY1115686T1 (fr)
DK (1) DK2516435T3 (fr)
ES (1) ES2503794T3 (fr)
GB (1) GB0922589D0 (fr)
HK (1) HK1171013A1 (fr)
IL (1) IL220153A (fr)
MX (1) MX2012007274A (fr)
NZ (1) NZ600453A (fr)
PL (1) PL2516435T3 (fr)
PT (1) PT2516435E (fr)
RU (1) RU2579513C2 (fr)
SG (1) SG181517A1 (fr)
SI (1) SI2516435T1 (fr)
WO (1) WO2011077098A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201205164D0 (en) * 2012-03-23 2012-05-09 Almac Discovery Ltd Pharmaceutical compounds
CA2971763A1 (fr) * 2014-12-23 2016-06-30 Bergenbio Asa Inhibiteurs de kinase akt
CN107428779A (zh) * 2015-02-27 2017-12-01 大鹏药品工业株式会社 咪唑并噁嗪晶体、含有所述晶体的药物组合物和制备所述晶体的方法
GB201603779D0 (en) 2016-03-04 2016-04-20 Mission Therapeutics Ltd Novel compounds
WO2018031407A1 (fr) 2016-08-07 2018-02-15 The Wistar Institute Of Anatomy And Biology Procédés de détection et de traitement d'une tumeur exprimant pt346 pdk1
MX2019015468A (es) * 2017-06-22 2020-08-03 Curadev Pharma Ltd Moduladores de moleculas pequeñas de sting humana.
CN111093663A (zh) 2017-09-07 2020-05-01 奥古斯塔大学研究所公司 特异性akt3激活剂及其用途
GB2600384A (en) 2020-09-30 2022-05-04 Vaderis Therapeutics Ag Allosteric AKT inhibitors for use in the treatment of hereditary hemorrhagic telangiectasia

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9702245A (es) * 1994-11-14 1997-06-28 Warner Lambert Co Seis-aril-pirido(2,3-d)pirimidinas y naftiridinas para inhibir la proliferacion celular mediada por la proteina cinasa tirosina.
TWI301760B (en) * 2004-02-27 2008-10-11 Merz Pharma Gmbh & Co Kgaa Tetrahydroquinolinones and their use as antagonists of metabotropic glutamate receptors
AU2005316826A1 (en) * 2004-12-15 2006-06-22 Merck Sharp & Dohme Corp. Inhibitors of Akt activity
CA2610888C (fr) * 2005-06-10 2011-02-08 Merck & Co., Inc. Inhibiteurs de l'activite akt
CA2656507C (fr) * 2006-07-17 2012-03-20 Amgen Inc. Derives de quinazoline et de pyridopyrimidine en tant qu'inhibiteurs de la p38 kinase
AR064010A1 (es) 2006-12-06 2009-03-04 Merck & Co Inc Inhibidores de la actividad de la akt
EP2120951A4 (fr) 2006-12-06 2012-02-15 Merck Sharp & Dohme Inhibiteurs de l'activité akt
US7999107B2 (en) * 2007-01-31 2011-08-16 Merck Sharp & Dohme Corp. Substituted pyrano[2,3-B]pyridine derivatives as cannabinoid-1 receptor modulators
WO2009148887A1 (fr) 2008-06-03 2009-12-10 Merck & Co., Inc. Inhibiteurs de l'activité akt
CA2726317A1 (fr) * 2008-06-03 2009-12-10 Merck Sharp & Dohme Corp. Inhibiteurs de l'activite akt

Also Published As

Publication number Publication date
CA2783340C (fr) 2015-11-24
MX2012007274A (es) 2012-10-03
JP2013515710A (ja) 2013-05-09
ES2503794T3 (es) 2014-10-07
AU2010334591A1 (en) 2012-06-21
DK2516435T3 (da) 2014-10-13
EP2516435B8 (fr) 2014-10-15
BR112012015677A2 (pt) 2015-06-30
CN102791708B (zh) 2016-03-02
WO2011077098A1 (fr) 2011-06-30
NZ600453A (en) 2013-10-25
US20130116243A1 (en) 2013-05-09
SI2516435T1 (sl) 2014-12-31
IL220153A0 (en) 2012-07-31
JP5923043B2 (ja) 2016-05-24
GB0922589D0 (en) 2010-02-10
PT2516435E (pt) 2014-11-13
WO2011077098A9 (fr) 2012-04-19
KR20140015157A (ko) 2014-02-06
RU2579513C2 (ru) 2016-04-10
PL2516435T3 (pl) 2015-01-30
CY1115686T1 (el) 2017-01-25
CA2783340A1 (fr) 2011-06-30
RU2012131115A (ru) 2014-01-27
EP2516435B1 (fr) 2014-08-06
SG181517A1 (en) 2012-07-30
AU2010334591C1 (en) 2014-07-31
IL220153A (en) 2015-05-31
AU2010334591B2 (en) 2014-04-10
CN102791708A (zh) 2012-11-21
EP2516435A1 (fr) 2012-10-31
US9221838B2 (en) 2015-12-29

Similar Documents

Publication Publication Date Title
EP2391623A4 (fr) Inhibiteurs de l'activité d'akt
EP2413932A4 (fr) Inhibiteurs de l'activité akt
EP2303269A4 (fr) Inhibiteurs de l'activité akt
EP2406250A4 (fr) Inhibiteurs de l'activité akt
ZA201700326B (en) Inhibitors of beta-secretase
HK1132676A1 (en) Inhibitors of akt activity akt
IL209488A0 (en) Inhibitors of akt activity
EP2405756A4 (fr) Inhibiteurs de l'activité akt
EP2114388A4 (fr) Inhibiteurs de l'activité de akt
HK1159102A1 (en) Inhibitors of ssao activity ssao
HK1171390A1 (en) Heparanase activity inhibitor
HK1137758A1 (en) Inhibitors of akt activity akt
EP2303852A4 (fr) Inhibiteurs d activité akt
EP2306825A4 (fr) Inhibiteurs de l'activité de l'akt
HK1171013A1 (en) Inhibitors of akt activity akt
EP2134175A4 (fr) Inhibiteurs de l'activité de akt
ZA201206456B (en) Uses of dgati inhibitors
HK1171624A1 (en) Inhibitors of cognitive decline
HK1167323A1 (en) Inhibitors of cognitive decline
EP2120951A4 (fr) Inhibiteurs de l'activité akt
EP2579872A4 (fr) Inhibiteurs de l'activité akt
EP2303277A4 (fr) Inhibiteurs de l'activité de l'akt
EP2303017A4 (fr) Inhibiteurs d activité akt
EP2303258A4 (fr) Inhibiteurs d activité akt
EP2513059A4 (fr) Inhibiteurs de l'activité akt

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20171223